Compared with bAVR at 5 years of follow-up, patients who underwent mAVR had similar rates of reoperation, congestive heart failure (CHF) readmission, overall bleeding events, and ischemic stroke; there was a slightly greater rate of cerebral hemorrhage among mAVR; however, this did not reach statistical significance.
← all excerpts
Cardiac valve prosthesis choice for left-sided infective endocarditis in Medicare patients.
1
—
—